Delivery Order SPE2DB22D2006-SPE2DB24FV8KA
Award Date
2/26/24
Potential Completion Date
2/27/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,010.40 for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 23, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,653.50 firm-fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product used for medical purposes. The contract has an ultimate completion date of April 12, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,173.40 firm fixed-price delivery order is for the supply of OMNIPAQUE 180 MG/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2022 and was awarded on March 31, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and DLA...
This federal contract award, valued at $3,444.85, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical supply product, with a performance period ending on January 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award was made without a set-aside designation, indicating open competition....
This federal contract award is for the delivery of Omnipaque 350 mg/ml Plus Pak 500 ml pharmaceutical products to the Defense Logistics Agency (DLA). The $5,597.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $5,597.12 and an ultimate completion date of February 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
This federal contract award, valued at $14,225.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Omnipaque 10ML VI 10S, a medical product, with a completion date of September 6, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00...
This federal contract award, valued at $4,643.77, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Omnipaque 350 mg/ml plus packs, which are pharmaceutical products used for medical imaging procedures. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Omnipaque 300 mg/ml vials to the Defense Logistics Agency (DLA). The Delivery Order has a ceiling value of $1,443.04 and a completion date of February 28, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Omnipaque 350 mg/ml infusion bottles with a 75ml capacity. The contract has a ceiling value of $4,926.05 and an ultimate completion date of September 29, 2021. This appears to be a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $2,279.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product, with a period of performance through February 16, 2024. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...